UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 203

Sortiert nach

Hyperhydration alone in children with acute lymphoblastic leukemia (ALL) at very low risk for developing tumor lysis syndrome (TLS)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e22012-e22012

2016

Link zum Volltext

Verfügbarkeit prüfen

Fever at diagnosis of pediatric acute lymphoblastic leukemia (ALL): Are antibiotics really necessary?

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.9553-9553

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcome in congenital hepatoblastoma compared with previously reported data

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10037-10037

2013

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4722-4729

2007

Link zum Volltext

Verfügbarkeit prüfen

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4722-4729

2010

Link zum Volltext

Verfügbarkeit prüfen

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

Journal of clinical oncology, 2008-01, Vol.26 (2), p.271-278

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9359-9368

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Journal of clinical oncology, 2004-01, Vol.22 (1), p.133-142

2004

Link zum Volltext

Verfügbarkeit prüfen

Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent Glioma

Journal of clinical oncology, 2011-07, Vol.29 (21), p.2918-2923

2011

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2013-03, Vol.31 (7), p.961-965

2013

Link zum Volltext

Verfügbarkeit prüfen

Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1304-1311

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Journal of clinical oncology, 2018-02, Vol.36 (4), p.326-332

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4196-4201

2006

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Recommendations for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2927-2941

2004

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Unemployment After Breast Cancer Surgery: A Systematic Review and Meta-Analysis of Observational Studies

Journal of clinical oncology, 2018-06, Vol.36 (18), p.1868-1879

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma

Journal of clinical oncology, 2003-02, Vol.21 (4), p.646-651

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2505-2512

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2681-2691

1999

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4733-4740

2009

Link zum Volltext

Verfügbarkeit prüfen

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3487-3495

2008

Link zum Volltext

Verfügbarkeit prüfen

Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study

Journal of clinical oncology, 2010-06, Vol.28 (18), p.3069-3075

2010

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial

Journal of clinical oncology, 2015-12, Vol.33 (35), p.4138-4144

2015

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Journal of clinical oncology, 2004-07, Vol.22 (13), p.2610-2616

2004

Link zum Volltext

Verfügbarkeit prüfen

Low-Stage Medulloblastoma: Final Analysis of Trial Comparing Standard-Dose With Reduced-Dose Neuraxis Irradiation

Journal of clinical oncology, 2000-08, Vol.18 (16), p.3004-3011

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 203

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(203)

Publikationsform

Artikel
(203)

Sprache

Englisch
(203)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(60)
Oncology
(56)
Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Biological And Medical Sciences
(52)
Female
(52)
Medical Sciences
(52)
Male
(46)
Middle Aged
(46)
Adult
(42)
Aged
(35)
Tumors
(27)
Treatment Outcome
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Pharmacology. Drug Treatments
(19)
Antineoplastic Agents
(18)
Brain Neoplasms - Drug Therapy
(15)
Drug Administration Schedule
(15)
Survival Analysis
(15)
Cancer Research
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(203)
Journals@Ovid Ovid Full Text
(203)
Single Journals
(203)
IngentaConnect Journals
(83)
IngentaConnect
(83)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Hyperhydration alone in children with acute lymphoblastic leukemia (ALL) at very low risk for developing tumor lysis syndrome (TLS)

Fever at diagnosis of pediatric acute lymphoblastic leukemia (ALL): Are antibiotics really necessary?

Outcome in congenital hepatoblastoma compared with previously reported data

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent Glioma

Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020

American Society of Clinical Oncology Recommendations for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer

Predictors of Unemployment After Breast Cancer Surgery: A Systematic Review and Meta-Analysis of Observational Studies

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Low-Stage Medulloblastoma: Final Analysis of Trial Comparing Standard-Dose With Reduced-Dose Neuraxis Irradiation

Aktive Filter

Suchergebnisse filtern